Log in

NASDAQ:WBAWalgreens Boots Alliance Stock Price, Forecast & News

$42.29
+0.07 (+0.17 %)
(As of 07/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$41.94
Now: $42.29
$43.48
50-Day Range
$39.60
MA: $42.32
$45.35
52-Week Range
$36.65
Now: $42.29
$64.50
Volume7.25 million shs
Average Volume7.01 million shs
Market Capitalization$37.10 billion
P/E Ratio10.84
Dividend Yield4.33%
Beta0.55
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services and mail services; and manages in-store clinics. As of August 31, 2018, this segment operated 9,560 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,767 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 618 optical practices, including 167 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. The company has a strategic partnership with Microsoft Corporation. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Read More
Walgreens Boots Alliance logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.7Dividend Strength: 5.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.51 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
Current SymbolNASDAQ:WBA
CUSIP93142210
Phone847-315-2500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$136.87 billion
Cash Flow$8.21 per share
Book Value$26.74 per share

Profitability

Net Income$3.98 billion

Miscellaneous

Employees342,000
Market Cap$37.10 billion
Next Earnings Date7/9/2020 (Confirmed)
OptionableOptionable

Receive WBA News and Ratings via Email

Sign-up to receive the latest news and ratings for WBA and its competitors with MarketBeat's FREE daily newsletter.

Walgreens Boots Alliance (NASDAQ:WBA) Frequently Asked Questions

How has Walgreens Boots Alliance's stock been impacted by COVID-19 (Coronavirus)?

Walgreens Boots Alliance's stock was trading at $46.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, WBA shares have decreased by 8.2% and is now trading at $42.29. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Walgreens Boots Alliance?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating and 13 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Walgreens Boots Alliance.

When is Walgreens Boots Alliance's next earnings date?

Walgreens Boots Alliance is scheduled to release its next quarterly earnings announcement on Thursday, July 9th 2020. View our earnings forecast for Walgreens Boots Alliance.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance Inc (NASDAQ:WBA) issued its earnings results on Thursday, April, 2nd. The pharmacy operator reported $1.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.46 by $0.06. The pharmacy operator had revenue of $35.82 billion for the quarter, compared to the consensus estimate of $35.24 billion. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The company's quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the business earned $1.64 EPS. View Walgreens Boots Alliance's earnings history.

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance announced a quarterly dividend on Wednesday, April 22nd. Investors of record on Wednesday, May 20th will be given a dividend of $0.4575 per share on Friday, June 12th. This represents a $1.83 dividend on an annualized basis and a yield of 4.33%. The ex-dividend date of this dividend is Tuesday, May 19th. View Walgreens Boots Alliance's dividend history.

What guidance has Walgreens Boots Alliance issued on next quarter's earnings?

Walgreens Boots Alliance issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, July, 9th. The company provided EPS guidance of 4.65-4.75 for the period, compared to the Thomson Reuters consensus estimate of $5.42.

What price target have analysts set for WBA?

14 Wall Street analysts have issued twelve-month target prices for Walgreens Boots Alliance's stock. Their forecasts range from $42.00 to $61.00. On average, they expect Walgreens Boots Alliance's share price to reach $49.23 in the next year. This suggests a possible upside of 16.4% from the stock's current price. View analysts' price targets for Walgreens Boots Alliance.

Has Walgreens Boots Alliance been receiving favorable news coverage?

Headlines about WBA stock have been trending negative recently, according to InfoTrie. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Walgreens Boots Alliance earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news coverage about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Walgreens Boots Alliance.

Are investors shorting Walgreens Boots Alliance?

Walgreens Boots Alliance saw a increase in short interest in June. As of June 30th, there was short interest totaling 18,290,000 shares, an increase of 18.2% from the June 15th total of 15,470,000 shares. Based on an average trading volume of 7,010,000 shares, the days-to-cover ratio is presently 2.6 days. Currently, 2.5% of the shares of the company are short sold. View Walgreens Boots Alliance's Current Options Chain.

Who are some of Walgreens Boots Alliance's key competitors?

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), CVS Health (CVS), Intel (INTC), Walt Disney (DIS), Johnson & Johnson (JNJ), General Electric (GE), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV) and Exxon Mobil (XOM).

Who are Walgreens Boots Alliance's key executives?

Walgreens Boots Alliance's management team includes the following people:
  • Mr. James A. Skinner, Exec. Chairman (Age 75)
  • Mr. Stefano Pessina, Exec. Vice Chairman & CEO (Age 78)
  • Mr. James Kehoe, Global Controller, CAO, Exec. VP & Global CFO (Age 57)
  • Mr. Alexander W. Gourlay, Co-Chief Operating Officer (Age 59)
  • Ms. Ornella Barra, Co-Chief Operating Officer (Age 66)

What is Walgreens Boots Alliance's stock symbol?

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's stock is owned by a variety of institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (0.05%), DNB Asset Management AS (0.05%), State of Alaska Department of Revenue (0.04%), Cardinal Capital Management Inc. (0.03%), Fulton Bank N. A. (0.00%) and OmniStar Financial Group Inc. (0.00%). Company insiders that own Walgreens Boots Alliance stock include Kathleen Wilson-Thompson, Kimberly R Scardino, Marco Patrick Anthony Pagni, Nancy M Schlichting, Ornella Barra, Stefano Pessina and William C Foote. View institutional ownership trends for Walgreens Boots Alliance.

Which institutional investors are selling Walgreens Boots Alliance stock?

WBA stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Legacy Capital Partners Inc., Bath Savings Trust Co, Truehand Inc, Woodstock Corp, IBM Retirement Fund, Home Federal Bank of Tennessee, and Clarius Group LLC. View insider buying and selling activity for Walgreens Boots Alliance.

Which institutional investors are buying Walgreens Boots Alliance stock?

WBA stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, DNB Asset Management AS, OmniStar Financial Group Inc., Cardinal Capital Management Inc., Fulton Bank N. A., Diversified Trust Co, Municipal Employees Retirement System of Michigan, and Red Spruce Capital LLC. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include Ornella Barra, and Stefano Pessina. View insider buying and selling activity for Walgreens Boots Alliance.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Walgreens Boots Alliance's stock price today?

One share of WBA stock can currently be purchased for approximately $42.29.

How big of a company is Walgreens Boots Alliance?

Walgreens Boots Alliance has a market capitalization of $37.10 billion and generates $136.87 billion in revenue each year. The pharmacy operator earns $3.98 billion in net income (profit) each year or $5.99 on an earnings per share basis. Walgreens Boots Alliance employs 342,000 workers across the globe.

What is Walgreens Boots Alliance's official website?

The official website for Walgreens Boots Alliance is www.walgreensbootsalliance.com.

How can I contact Walgreens Boots Alliance?

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.